Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-11.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Difference of the Nuclear Green Light Intensity between Papillary Carcinoma Cells Showing Clear Nuclei and Non-neoplastic Follicular Epithelia in Papillary Thyroid Carcinoma
Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Pathol Transl Med > Volume 50(5); 2016 > Article
Original Article
Difference of the Nuclear Green Light Intensity between Papillary Carcinoma Cells Showing Clear Nuclei and Non-neoplastic Follicular Epithelia in Papillary Thyroid Carcinoma
Hyekyung Lee, Tae Hwa Baek1, Meeja Park, Seung Yun Lee, Hyun Jin Son, Dong Wook Kang, Joo Heon Kim, Soo Young Kim,2
Journal of Pathology and Translational Medicine 2016;50(5):355-360.
DOI: https://doi.org/10.4132/jptm.2016.05.19
Published online: August 22, 2016

Department of Pathology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea

1Medical Examiner’s Office, National Forensic Service, Wonju, Korea

2Department of Occupational Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea

Corresponding Author Soo Young Kim, MD Department of Pathology, Eulji University Hospital, 95 Dunsanseo-ro, Seo-gu, Daejeon 35233, Korea Tel: +82-42-611-3782 Fax: +82-42-611-3776 E-mail: kimsooy@eulji.ac.kr
• Received: March 11, 2016   • Revised: May 3, 2016   • Accepted: May 19, 2016

© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 6,727 Views
  • 89 Download
  • Background
    There is subjective disagreement regarding nuclear clearing in papillary thyroid carcinoma. In this study, using digital instruments, we were able to quantify many ambiguous pathologic features and use numeric data to express our findings.
  • Methods
    We examined 30 papillary thyroid carcinomas. For each case, we selected representative cancer cells showing clear nuclei and surrounding non-neoplastic follicular epithelial cells and evaluated objective values of green light intensity (GLI) for quantitative analysis of nuclear clearing in papillary thyroid carcinoma.
  • Results
    From 16,274 GLI values from 600 cancer cell nuclei and 13,752 GLI values from 596 non-neoplastic follicular epithelial nuclei, we found a high correlation of 94.9% between GLI and clear nuclei. GLI between the cancer group showing clear nuclei and non-neoplastic follicular epithelia was statistically significant. The overall average level of GLI in the cancer group was over two times higher than the non-neoplastic group despite a wide range of GLI. On a polygonal line graph, there was a fluctuating unique difference between both the cancer and non-neoplastic groups in each patient, which was comparable to the microscopic findings.
  • Conclusions
    Nuclear GLI could be a useful factor for discriminating between carcinoma cells showing clear nuclei and non-neoplastic follicular epithelia in papillary thyroid carcinoma.
In the diagnosis of papillary thyroid carcinoma, nuclear characteristics are important. Among the nuclear triad composed of clear nuclei, nuclear grooves and pseudoinclusions, nuclear clearing is the most subjective and most ambiguous finding [1]. Currently, with the use of digital instruments, we are able to quantify many ambiguous pathologic features and express our findings with numeric data [2-6]. Based on a previous study that described the meaningful data of nuclear green light intensity (GLI) in neuroendocrine tumors [7], we hypothesized that the nuclear clearing of papillary thyroid carcinoma could be also expressed using GLI because both tumors share similar nuclear features with relatively homogeneous nuclei without irregular chromatin clumping. We measured the GLI of cancer cells showing clear nuclei and surrounding non-neoplastic follicular epithelial nuclei in papillary thyroid carcinoma patients and evaluated the significance of GLI as a discriminator between the two groups.
A total of 30 thyroidectomy specimens with papillary carcinoma were retrospectively selected from the Department of Pathology and Laboratory Medicine archives of the Eulji University Hospital. We cut formalin-fixed, paraffin-embedded tissues into 3-µm sections, and stained all sections simultaneously with hematoxylin and eosin using an automatic slide staining machine under standard conditions. We reviewed the slides on an Olympus BX51 microscope (Olympus Corp., Tokyo, Japan) with ×40 magnification of the apochromatic objective lens and a 0.85 numeric aperture. We maintained the same light source conditions throughout the analysis. Clear nuclei were determined by two pathologists (H.L. and M.P.). We captured digital images (1,360×1,024 pixels) of typical areas showing cancer cells with clear nuclei and surrounding non-neoplastic nuclei by using an Olympus DP71 digital camera (Olympus Corp.) and saved the images in Tagged Image File Format format. We reviewed each digital image and removed any image that did not fulfill the minimum requirements (bad nuclear mask, out-of-focus image, pyknotic nucleus). For each case, we selected 20 representative cancer cells with clear nuclei and 20 surrounding non-neoplastic follicular epithelial nuclei except for case 1. For each cell, we drew line profiles using computerized image analyzer (Image Pro program Plus ver. 6.5, Media Cybertics Co., Silver Spring, MD, USA) and obtained graph files and Excel data on GLIs of consecutive pixels along the line profiles. For comparison between the two groups, statistical analysis was performed with a nonparametric Mann-Whitney U test and p<.05 was considered significant.
A total of 600 cancer cell nuclei and 596 non-neoplastic follicular epithelial nuclei were selected from 30 papillary thyroid carcinoma patients. The 16,274 GLI values from 600 cancer cell nuclei and 13,752 GLI values from 596 non-neoplastic follicular epithelial nuclei were studied (Table 1, Fig. 1). We sought to determine whether GLI could be used to identify clear nuclei of the cancer group by comparison with the non-neoplastic group. There was a high correlation of 94.9% between GLI and clear nuclei on the receiver operating characteristic (ROC) curve (Fig. 2). There was a significant increase in GLI in the cancer group (GLI median, standard deviation); with values of 51, 20 for the non-neoplastic group compared to 105, 29 for the cancer group, which was statistically significant (Fig. 3). On a polygonal line graph of an equal number of GLI from the cancer group and non-neoplastic group in each patient, there was a fluctuating difference between each patient, but there was a higher difference in the cancer group (Fig. 4). The microscopic findings of cases 9, 14, and 25 who showed more GLI difference between the two groups revealed more clear nuclei in cancer cells (Fig. 5A), whereas cases 5, 6, and 26 showed less GLI difference between the two groups with less clear nuclei in cancer cells (Fig. 5B). Each patient showed unique identifiable patterns in both the cancer and non-neoplastic groups.
Nuclear examination of cells is important in pathology. Several characteristic nuclear features of clinical significance have been described. Hyperchromatism is an expression of increased DNA content due to cellular proliferation and mitosis is an expression of rapid cellular division. Coffee bean-like nuclear grooves, ground glass nuclei, and nuclear pseudoinclusions are meaningful in the diagnosis for specific diseases such as papillary thyroid carcinoma. Among those nuclear features, pseudoinclusions or grooves are relatively objective findings with either presence or absence documented. However, some features such as clear nuclei, vesicular nuclei, and homogenized nuclei are relatively subjective findings and their diagnosis is subject to interobserver variability. Many pathologists have been trying to minimize interobserver variability for some time. Currently, by using a more developed digital imaging system, we are able to translate subjective and ambiguous pathologic findings into objective data. With these data, we can reduce interobserver variability and introduce a new era of data based research. Papillary thyroid carcinoma is a well-known tumor in the sense that appropriate nuclear features are essential for making the diagnosis. Among these diagnostic nuclear features, clear nuclei are relatively subjective and shows significant interobserver variability. Several questions regarding clear nuclei remain, including the following. What degree of clearance is enough for the diagnosis of clear nuclei of papillary carcinoma? Is the level of clearing the same in usual papillary thyroid carcinomas? Is there any recommended method to measure the clearing? Unfortunately, the recommended and standard method for measuring nuclear clearing is not yet known. When we considered these issues, we realized the necessity of measurable data regarding the degree and level of nuclear clearing. In addition to quantitative studies regarding nuclear morphometry characteristics such as variation in nuclear size, irregularity in nuclear contours, and chromatin texture [3-7] red, green, and blue color charts have also been used to calibrate digital graphic devices [8,9]. A recent study described red, green, and blue light intensities for nuclear chromatin pattern of neuroendocrine cells and stressed the importance of GLI [7]. We attempted to answer the above questions by quantitatively measuring objective GLI values. In the materials and methods section, we questioned whether single line profile can be used instead of different orientations (0°, 45°, 90°, and 135°). In a short preliminary study (unpublished data) we could not find big differences between those groups and in practice, it was not easy to draw a line profile of different angles because we had to avoid nuclear grooves and pseudoinclusions. In the results analysis, by comparing the GLI between the cancer group with clear nuclei and the non-neoplastic internal control group, we were able to reduce the possible errors that affect digital image analysis, namely specimen thickness, staining, and interference due to the brightness around the line profiles. Fig. 2 shows a high concordance of 94.9% between the carcinoma groups and GLI in the ROC curve study. Fig. 3 shows the difference in GLI between the cancer group showing clear nuclei and the non-neoplastic group, which was statistically significant. Based on these results, we suggest that the presence of clear nuclei is highly correlated with GLI and that GLI could be a meaningful discriminator between cancer and non-neoplastic groups. Fig. 4 shows the fluctuating difference of GLI in both cancer and non-neoplastic groups in each case, with an even higher difference in the cancer group. The higher fluctuation in the cancer group seems to be related to the higher standard deviation described in Table 1. In cases 5, 6, and 26, the GLI difference between the cancer and non-neoplastic groups was not significant; however in cases 9, 14, and 25, the difference between the two groups was significant. These differences in GLI were easily identified by microscopic examination for clear nuclei (Fig. 5). Based on such differences in GLI compared with the microscopic findings in each case, we were able to answer the second question as follows: the level of clearing is not the same in all thyroid papillary carcinomas. When we considered that nuclear clearing can be related to nuclear microfilament localization or hypochromatism in tumor progression [10,11] with the wide range of light intensity, the nuclear clearing could be an expression of gradual tumor progression rather than a sudden onset phenomenon. The pathogenesis of a clear nucleus is not completely understood. The effects of thyroid hormone on Na/K-ATPase activity have been studied and the functions of the Na/K-ATPase of the nuclear envelope in ion transport and chromatin modulation have been described [12-15]. Therefore, the characteristic nuclear triad of papillary thyroid carcinoma, which consists of nuclear grooves, pseudoinclusions, and clearing, can be secondary findings due to an abnormal Na/K-ATPase affected by abnormal thyroid hormone in papillary thyroid carcinoma. Because of the wide range of GLI, we could not generate a diagnostically helpful cut-off value or function for the discrimination between the cancer group showing clear nuclei and non-neoplastic group. However, with over 30,000 GLI data points, we believe that an average level of GLI at least two times higher in the cancer group (104.9) than the non-neoplastic group (50.8) is meaningful. For example, in thyroid tissue section showing big difference over two times of GLI of each cell, although we can’t definitely discriminate between cancer cells showing clear nuclei and normal cells only by GLI values, we could consider the possibility of papillary carcinoma in the tissue section. Moreover we can apply these results in cytology, where automatic screening is relatively popular. However, there are still many problems to be solved, such as common nuclear clearing in autoimmune thyroiditis and proper quality control and adjustment for different samples. Recently, Louis et al. [16,17] defined computational pathology as an approach to extract clinically actionable knowledge from variable data, including digital images, and suggested that computational pathology should serve as a hub for data-related research in modern health care systems. By using newly developed information and technology tools, we can review and reanalyze our traditional pathologic findings and with those efforts, we can expand our understanding of diseases and obtain more objective and reproducible methods of diagnosis. In conclusion, quantitative analysis of the nuclear GLI for the discrimination between cancer cells showing clear nuclei and non-neoplastic follicular epithelial cells in papillary thyroid carcinoma revealed meaningful results comparable to traditional microscopic findings. Nuclear GLI could be a useful factor for the discrimination between these two groups.
Fig. 1.
Plot box graph of green light intensity (GLI) of cancer cells and non-neoplastic cells in 30 papillary thyroid carcinoma patients. Error bar, 5th and 95th percentiles; line, central 50th percentile; triangle for cancer, circle for non-neoplastic group, mean GLI.
jptm-2016-05-19f1.gif
Fig. 2.
High correlation of green light intensity with nuclear clearing in receiver operating characteristic curve (ROC).
jptm-2016-05-19f2.gif
Fig. 3.
Comparison of green light intensity (GLI) between papillary thyroid carcinoma showing clear nuclei and surrounding non-neoplastic follicular epithelial cells.
jptm-2016-05-19f3.gif
Fig. 4.
Fluctuating difference of green light intensity (GLI) in both cancer and non-neoplastic groups between each patient on polygonal line graph (red, non-neoplastic cells; blue, cancer).
jptm-2016-05-19f4.gif
Fig. 5.
(A) Comparison of green light intensity (GLI) of cancer cells and non-neoplastic cells in case 25, which shows a large difference (left, cancer; right, non-neoplastic cells). (B) Comparison of GLI of cancer cells and non-neoplastic cells in case 26, where there is no significant difference (left, cancer; right, non-neoplastic cells). Note the similarity in red, green, and blue light intensities of non-neoplastic follicular epithelial cells in panel A and B.
jptm-2016-05-19f5.gif
Table 1.
The number of GLI of cancer cells and non-neoplastic cells in 30 papillary thyroid carcinoma patients
Patient No. No. of cancer cells No. of GLI of cancer No. of non-neoplastic cells No. of GLI of non-neoplastic cells
1 20 533 16 354
2 20 542 20 470
3 20 558 20 435
4 20 485 20 443
5 20 463 20 417
6 20 372 20 377
7 20 483 20 467
8 20 433 20 373
9 20 466 20 401
10 20 497 20 342
11 20 476 20 367
12 20 423 20 415
13 20 442 20 345
14 20 452 20 380
15 20 449 20 427
16 20 546 20 434
17 20 496 20 424
18 20 635 20 428
19 20 519 20 459
20 20 537 20 455
21 20 547 20 417
22 20 521 20 414
23 20 508 20 437
24 20 575 20 425
25 20 750 20 605
26 20 623 20 662
27 20 798 20 604
28 20 760 20 692
29 20 630 20 625
30 20 755 20 658
Total 600 16,274 596 13,752

GLI, green light intensity.

  • 1. LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol 2011; 24 Suppl 2: S1-9. ArticlePubMed
  • 2. Neltner JH, Abner EL, Schmitt FA, et al. Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. J Neuropathol Exp Neurol 2012; 71: 1075-85. ArticlePubMedPMC
  • 3. El Hallani S, Guillaud M, Korbelik J, Marginean EC. Evaluation of quantitative digital pathology in the assessment of Barrett eophagus-associated dysplasia. Am J Clin Pathol 2015; 144: 151-64. ArticlePubMed
  • 4. Guillaud M, Zhang L, Poh C, Rosin MP, MacAulay C. Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Res 2008; 68: 3099-107. ArticlePubMedPMC
  • 5. Huang W, Hennrick K, Drew S. A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Hum Pathol 2013; 44: 29-38. ArticlePubMed
  • 6. Kayser K, Görtler J, Goldmann T, Vollmer E, Hufnagl P, Kayser G. Image standards in tissue-based diagnosis (diagnostic surgical pathology). Diagn Pathol 2008; 3: 17.ArticlePubMedPMC
  • 7. Park M, Baek T, Baek J, et al. Nuclear image analysis study of neuroendocrine tumors. Korean J Pathol 2012; 46: 38-41. ArticlePubMedPMC
  • 8. Yagi Y. Color standardization and optimization in whole slide imaging. Diagn Pathol 2011; 6 Suppl 1: S15.ArticlePubMed
  • 9. Bautista PA, Hashimoto N, Yagi Y. Color standardization in whole slide imaging using a color calibration slide. J Pathol Inform 2014; 5: 4.ArticlePubMedPMC
  • 10. Johannessen JV, Gould VE, Jao W. The fine structure of human thyroid cancer. Hum Pathol 1978; 9: 385-400. ArticlePubMed
  • 11. Fischer AH, Taysavang P, Weber CJ, Wilson KL. Nuclear envelope organization in papillary thyroid carcinoma. Histol Histopathol 2001; 16: 1-14. ArticlePubMed
  • 12. Lin MH, Akera T. Increased (Na+,K+)-ATPase concentrations in various tissues of rats caused by thyroid hormone treatment. J Biol Chem 1978; 253: 723-6. ArticlePubMed
  • 13. Kamitani T, Ikeda U, Muto S, et al. Regulation of Na,K-ATPase gene expression by thyroid hormone in rat cardiocytes. Circ Res 1992; 71: 1457-64. ArticlePubMed
  • 14. Liu Y, Levine B. Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ 2015; 22: 367-76. ArticlePubMed
  • 15. Garner MH. Na,K-ATPase in the nuclear envelope regulates Na+: K+ gradients in hepatocyte nuclei. J Membr Biol 2002; 187: 97-115. ArticlePubMed
  • 16. Louis DN, Gerber GK, Baron JM, et al. Computational pathology: an emerging definition. Arch Pathol Lab Med 2014; 138: 1133-8. ArticlePubMed
  • 17. Louis DN, Feldman M, Carter AB, et al. Computational pathology: a path ahead. Arch Pathol Lab Med 2016; 140: 41-50. ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Difference of the Nuclear Green Light Intensity between Papillary Carcinoma Cells Showing Clear Nuclei and Non-neoplastic Follicular Epithelia in Papillary Thyroid Carcinoma
        J Pathol Transl Med. 2016;50(5):355-360.   Published online August 22, 2016
        Close
      • XML DownloadXML Download
      Figure
      • 0
      • 1
      • 2
      • 3
      • 4
      Difference of the Nuclear Green Light Intensity between Papillary Carcinoma Cells Showing Clear Nuclei and Non-neoplastic Follicular Epithelia in Papillary Thyroid Carcinoma
      Image Image Image Image Image
      Fig. 1. Plot box graph of green light intensity (GLI) of cancer cells and non-neoplastic cells in 30 papillary thyroid carcinoma patients. Error bar, 5th and 95th percentiles; line, central 50th percentile; triangle for cancer, circle for non-neoplastic group, mean GLI.
      Fig. 2. High correlation of green light intensity with nuclear clearing in receiver operating characteristic curve (ROC).
      Fig. 3. Comparison of green light intensity (GLI) between papillary thyroid carcinoma showing clear nuclei and surrounding non-neoplastic follicular epithelial cells.
      Fig. 4. Fluctuating difference of green light intensity (GLI) in both cancer and non-neoplastic groups between each patient on polygonal line graph (red, non-neoplastic cells; blue, cancer).
      Fig. 5. (A) Comparison of green light intensity (GLI) of cancer cells and non-neoplastic cells in case 25, which shows a large difference (left, cancer; right, non-neoplastic cells). (B) Comparison of GLI of cancer cells and non-neoplastic cells in case 26, where there is no significant difference (left, cancer; right, non-neoplastic cells). Note the similarity in red, green, and blue light intensities of non-neoplastic follicular epithelial cells in panel A and B.
      Difference of the Nuclear Green Light Intensity between Papillary Carcinoma Cells Showing Clear Nuclei and Non-neoplastic Follicular Epithelia in Papillary Thyroid Carcinoma
      Patient No. No. of cancer cells No. of GLI of cancer No. of non-neoplastic cells No. of GLI of non-neoplastic cells
      1 20 533 16 354
      2 20 542 20 470
      3 20 558 20 435
      4 20 485 20 443
      5 20 463 20 417
      6 20 372 20 377
      7 20 483 20 467
      8 20 433 20 373
      9 20 466 20 401
      10 20 497 20 342
      11 20 476 20 367
      12 20 423 20 415
      13 20 442 20 345
      14 20 452 20 380
      15 20 449 20 427
      16 20 546 20 434
      17 20 496 20 424
      18 20 635 20 428
      19 20 519 20 459
      20 20 537 20 455
      21 20 547 20 417
      22 20 521 20 414
      23 20 508 20 437
      24 20 575 20 425
      25 20 750 20 605
      26 20 623 20 662
      27 20 798 20 604
      28 20 760 20 692
      29 20 630 20 625
      30 20 755 20 658
      Total 600 16,274 596 13,752
      Table 1. The number of GLI of cancer cells and non-neoplastic cells in 30 papillary thyroid carcinoma patients

      GLI, green light intensity.


      J Pathol Transl Med : Journal of Pathology and Translational Medicine
      TOP